Methods for Derivation of Human Embryonic Stem Cells

¹ Department of Obstetrics and Gynecology, Institute of Reproductive Medicine and Population, Medical Research Center, College of Medicine, Seoul National University, Seoul, Korea
² Institute of Reproductive Medicine and Population, Medical Research Center, College of Medicine, Seoul National University, Seoul, Korea, Central Research Institute, Sam Jin Pharm. Co. Ltd., Hwasung, Korea
³ Institute of Reproductive Medicine and Population, Medical Research Center, College of Medicine, Seoul National University, Seoul, Korea
⁴ Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Korea
⁵ Department of Obstetrics and Gynecology, Institute of Reproductive Medicine and Population, Medical Research Center, College of Medicine, Seoul National University, Seoul, Korea, Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea
⁶ Department of Physiology, Yonsei University College of Medicine, Seoul, Korea

^* To whom correspondence should be addressed. E-mail: shmoon{at}plaza.snu.ac.kr.

	Abstract

The expanded blastocysts, developed from 2PN stage embryos, are generally divided into three categories: a good blastocyst containing a large and distinguishable inner cell mass (ICM), a blastocyst with a small and distinct ICM, and a blastocyst with a poorly-defined ICM. Here, we introduce methods for the derivation of human embryonic stem cells (hESCs) depending on the quality of the blastocysts. Immunosurgical method was employed for the good expanded blastocysts. This method, however, raises the probability of ICM loss in cases of hESC derivation from blastocysts with smaller or indistinct ICM. Furthermore, this method is also associated with a risk of the contamination of the hESC with animal pathogens. To overcome these shortcomings, the partial or whole embryo culture method was used. For blastocysts with no visible ICM, the whole embryo culture method was used to establish hESC via the seeding of the entire blastocyst without its zona pellucida directly on a STO feeder layer. However, trophectodermal overgrowth tends to hinder the expansion of the ICM during the initial steps of hESC derivation. Therefore, the partial embryo culture method was developed to establish hESCs from blastocysts with smaller ICMs. The surgical isolation of the region containing the ICM with an ultra-fine glass pipette alleviates trophectoderm overgrowth. This method is also applicable to blastocysts with large and distinct ICMs, and the efficiency of this method is comparable to that of the immunosurgical method.

This article has been cited by other articles:

				C. Unger, H. Skottman, P. Blomberg, M. Sirac Dilber, and O. Hovatta Good manufacturing practice and clinical-grade human embryonic stem cell lines Hum. Mol. Genet., April 15, 2008; 17(R1): R48 - R53. [Abstract] [Full Text] [PDF]

				T. Li, C. Zhou, C. Liu, Q. Mai, and G. Zhuang Bulk vitrification of human embryonic stem cells Hum. Reprod., February 1, 2008; 23(2): 358 - 364. [Abstract] [Full Text] [PDF]

				C. E. Gargett Review Article: Stem Cells in Human Reproduction Reproductive Sciences, July 1, 2007; 14(5): 405 - 424. [Abstract] [PDF]

				H. Skottman and O. Hovatta Culture conditions for human embryonic stem cells. Reproduction, November 1, 2006; 132(5): 691 - 698. [Abstract] [Full Text] [PDF]

				E. H. Lee and J. H. P. Hui The potential of stem cells in orthopaedic surgery J Bone Joint Surg Br, July 1, 2006; 88-B(7): 841 - 851. [Full Text] [PDF]

				A. Trounson The Production and Directed Differentiation of Human Embryonic Stem Cells Endocr. Rev., April 1, 2006; 27(2): 208 - 219. [Abstract] [Full Text] [PDF]